CHIRICOZZI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 7.129
AS - Asia 899
EU - Europa 856
SA - Sud America 119
AF - Africa 22
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 3
Totale 9.033
Nazione #
US - Stati Uniti d'America 7.086
SG - Singapore 374
CN - Cina 232
IT - Italia 147
RU - Federazione Russa 144
BR - Brasile 104
DE - Germania 93
UA - Ucraina 84
FR - Francia 80
HK - Hong Kong 77
VN - Vietnam 67
SE - Svezia 57
IE - Irlanda 55
GB - Regno Unito 53
PL - Polonia 44
IN - India 36
CA - Canada 31
FI - Finlandia 29
NL - Olanda 25
JP - Giappone 23
KR - Corea 19
BD - Bangladesh 18
ES - Italia 11
AR - Argentina 10
MX - Messico 8
TR - Turchia 8
UZ - Uzbekistan 7
ZA - Sudafrica 7
AT - Austria 6
RO - Romania 6
CH - Svizzera 5
ID - Indonesia 5
KG - Kirghizistan 5
LT - Lituania 5
MY - Malesia 5
PH - Filippine 5
MA - Marocco 4
AU - Australia 3
BE - Belgio 3
DZ - Algeria 3
EG - Egitto 3
EU - Europa 3
PK - Pakistan 3
CZ - Repubblica Ceca 2
GA - Gabon 2
GH - Ghana 2
HR - Croazia 2
IL - Israele 2
IQ - Iraq 2
OM - Oman 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AW - Aruba 1
CL - Cile 1
CO - Colombia 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
GI - Gibilterra 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
LB - Libano 1
MM - Myanmar 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PY - Paraguay 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TW - Taiwan 1
VE - Venezuela 1
Totale 9.033
Città #
Woodbridge 2.027
Wilmington 1.735
Houston 1.514
Singapore 252
Fairfield 218
Ashburn 173
Chandler 145
Ann Arbor 126
Seattle 83
San Jose 80
Hong Kong 77
Cambridge 76
Jacksonville 68
Beijing 67
Dearborn 64
New York 60
Dublin 54
Medford 45
Rome 38
Kraków 37
The Dalles 37
Zhengzhou 36
Santa Clara 32
Los Angeles 26
Council Bluffs 24
Ho Chi Minh City 24
Tokyo 23
Lawrence 21
Buffalo 20
Dallas 19
Hanoi 18
Lauterbourg 18
Milan 15
Moscow 15
Munich 15
San Diego 15
São Paulo 14
Amsterdam 13
Menlo Park 12
Montreal 11
Norwalk 11
Redondo Beach 10
Shanghai 9
Helsinki 8
Palo Alto 8
Hefei 7
Nanjing 7
Poplar 7
Toronto 7
Warsaw 7
Boardman 6
Brooklyn 6
Chennai 6
Chicago 6
Denver 6
Detroit 6
Dhaka 6
Frankfurt am Main 6
Johannesburg 6
Kunming 6
Orem 6
Columbus 5
London 5
Mumbai 5
Phoenix 5
Bari 4
Engelhard 4
Fuzhou 4
Nanchang 4
Philadelphia 4
Redwood City 4
San Antonio 4
Verona 4
Boston 3
Brussels 3
Catania 3
Elk Grove Village 3
Esslingen am Neckar 3
Fortaleza 3
Goiânia 3
Guangzhou 3
Ludhiana 3
Manchester 3
Mexico City 3
Newark 3
Paris 3
Pune 3
Salt Lake City 3
Trieste 3
Turin 3
Vienna 3
Accra 2
Ankara 2
Araguari 2
Araçatuba 2
Atlanta 2
Auburn Hills 2
Basel 2
Bexley 2
Brno 2
Totale 7.618
Nome #
Efficacy and safety of infliximab in psoriatic patients over the age of 65 552
AISI: A New Disease Severity Assessment Tool for Hidradenitis Suppurativa 532
Apremilast for the treatment of psoriasis. 477
Psoriasis Phenotype in Inflammatory Bowel Disease: A Case-Control Prospective Study 477
Increased levels of IL-17 in tear fluid of moderate-to-severe psoriatic patients is reduced by adalimumab therapy 454
Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis 448
Role of IL-23 in the pathogenesis of psoriasis: A novel potential therapeutic target? 444
Real-life 9-year experience with adalimumab in psoriasis and psoriatic arthritis: results of a single-centre, retrospective study. 422
Usefulness of QuantiFERON®-TB Gold test in psoriatic patients under treatment with tumour necrosis factor blockers 414
Quality-of-life impairment in hidradenitis suppurativa 410
Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis 405
Quality of life of psoriatic patients evaluated by a new psychometric assessment tool: PsoDisk 395
Immunologic biomarkers for clinical and therapeutic management of psoriasis 381
Small molecules and antibodies for the treatment of psoriasis: A patent review (2010–2015) 371
Serum Protein Profile Changes in Psoriatic Patients Undergoing Treatment With Infliximab 365
Tofacitinib for the treatment of moderate-to-severe psoriasis 356
Biomolecular index of therapeutic efficacy in psoriasis treated by anti-TNF alpha agents. 343
Characterization of comorbid conditions burdening hidradenitis suppurativa: a multicentric observational study 338
Etanercept biosimilar SB4 in the treatment of chronic plaque psoriasis: data from the Psobiosimilars registry 336
Assessement of disease severity and treatment effectiveness in hidradenitis suppurtiva 333
Alexithymia affects patients with hidradenitis suppurativa 310
Dupilumab Treatment in Children Aged 6-11 Years With Atopic Dermatitis: A Multicentre, Real-Life Study 118
A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years 111
Anogenital involvement: Clinical sign of severity in hidradenitis suppurativa 92
Factors related to the onset and recurrence of flares in hidradenitis suppurativa patients treated with adalimumab 82
Long-Term Persistence Rate of Secukinumab in Psoriatic Patients: A Six-Year Multicenter, Real-World Experience, Retrospective Study 78
Apheresis in the treatment of recalcitrant atopic dermatitis: Case series and review of the literature 65
Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study 63
Certolizumab for the treatment of psoriasis and psoriatic arthritis: a real-world multicentre Italian study 60
Totale 9.232
Categoria #
all - tutte 21.444
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.444


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022211 13 22 21 13 8 19 10 8 14 20 17 46
2022/2023323 27 29 15 49 29 66 24 18 36 3 13 14
2023/2024177 19 1 10 5 13 39 8 16 4 15 7 40
2024/2025614 23 133 65 66 14 41 73 30 35 55 55 24
2025/20261.188 94 50 141 153 106 30 149 148 113 98 53 53
2026/20271 1 0 0 0 0 0 0 0 0 0 0 0
Totale 9.232